# First in Men Study: BIOMAG-I

> **NCT04157153** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Biotronik AG** · enrollment: 116 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Implantation of a Sirolimus-Eluting Resorbable Coronary Magnesium Scaffold

## Key facts

- **NCT ID:** NCT04157153
- **Lead sponsor:** Biotronik AG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-04-27
- **Primary completion:** 2022-08
- **Final completion:** 2027-02
- **Target enrollment:** 116 (ACTUAL)
- **Last updated:** 2022-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04157153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04157153, "First in Men Study: BIOMAG-I". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04157153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*